AU7615100A - Vasopressin antagonist and diuretic combination - Google Patents

Vasopressin antagonist and diuretic combination

Info

Publication number
AU7615100A
AU7615100A AU76151/00A AU7615100A AU7615100A AU 7615100 A AU7615100 A AU 7615100A AU 76151/00 A AU76151/00 A AU 76151/00A AU 7615100 A AU7615100 A AU 7615100A AU 7615100 A AU7615100 A AU 7615100A
Authority
AU
Australia
Prior art keywords
vasopressin antagonist
diuretic combination
diuretic
combination
vasopressin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76151/00A
Inventor
Evelyn Jane Ellis Grosse
Gayle Penniman Orczyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU7615100A publication Critical patent/AU7615100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU76151/00A 1999-09-27 2000-09-26 Vasopressin antagonist and diuretic combination Abandoned AU7615100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40665899A 1999-09-27 1999-09-27
US09406658 1999-09-27
PCT/US2000/026370 WO2001023366A2 (en) 1999-09-27 2000-09-26 Vasopressin antagonist and diuretic combination

Publications (1)

Publication Number Publication Date
AU7615100A true AU7615100A (en) 2001-04-30

Family

ID=23608937

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76151/00A Abandoned AU7615100A (en) 1999-09-27 2000-09-26 Vasopressin antagonist and diuretic combination

Country Status (3)

Country Link
AR (1) AR030916A1 (en)
AU (1) AU7615100A (en)
WO (1) WO2001023366A2 (en)

Also Published As

Publication number Publication date
WO2001023366A3 (en) 2001-06-07
AR030916A1 (en) 2003-09-03
WO2001023366A2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU5826100A (en) Benzazepinones and quinazolines
AU3213799A (en) Integrin antagonists
AU7315800A (en) Mch antagonists
AU7079498A (en) Neuropeptide y receptor antagonist
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU5240400A (en) Barrier
AU5786300A (en) Muscarinic antagonists
AU1152601A (en) Compositions and their use
AUPQ488899A0 (en) Scaffolding
AU6826598A (en) Endothelin-receptor antagonists
AU4543300A (en) Sunscreen agents
AU5569200A (en) Uracil compounds and use thereof
AU6302100A (en) Domed construction
AU7654800A (en) Quinazolinones
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2669201A (en) Taccalonolides and their use
AU5979300A (en) Angiopoietin-6 and uses thereof
AU7615100A (en) Vasopressin antagonist and diuretic combination
AU7447600A (en) Antiobestic agents
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
ZA200203312B (en) Vasopressin antagonist formulation and process.
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase